is a European peer-reviewed scientific journal devoted to the epidemiology, surveillance,
prevention and control of communicable diseases, with a focus on such topics that are of relevance to Europe.
It is a weekly online journal, with 50 issues per year published on Thursdays, and features short rapid communications,
longer in-depth research articles, surveillance and outbreak reports, reviews and perspective papers, as well as short news items.
Timely publication of short authoritative papers on ongoing outbreaks or other relevant public health events is one of the major assets of the journal.
Under special circumstances when current events need to be urgently communicated to readers for rapid public health action,
e-alerts can be released outside of the regular publishing schedule.
Topical compilations of selected articles and special issues are also published in print.
The entire content is open access, free of charge for both readers and authors.
All articles are indexed in the PubMed/MEDLINE, Scopus, EMBASE and EBSCO databases.
The journal has been selected for coverage by Thomson Reuters and is indexed and abstracted in the Science Citation Index Expanded
(also known as SciSearch) and in the Journal Citation Reports/Science Edition beginning with volume 14(1) 2009.
The current impact factor, for the year 2014, is 5.722 (Journal Citation Reports, Thomson Reuters, 2015).
This places Eurosurveillance
at rank 6 among the 78 journals in the category Infectious Diseases.
The Scopus-based SCImago Journal Rank (SJR) for 2014 ranks Eurosurveillance 92 of 1,775 journals in the category Medicine.
The journal is also in the first quarter (Q1) in the categories Epidemiology, Public Health, Environmental and Occupational Health and Virology.
Google Scholar metrics in mid-2014 listed Eurosurveillance
at ranks 4 and 10 among journals in the categories Epidemiology and
Approximately 11,700 active subscribers receive the weekly table of contents via email. In 2014, 68 peer-reviewed rapid communications and
137 peer-reviewed long articles were published in Eurosurveillance
, by authors from ca 60 countries worldwide,
as well as 83 editorials, news pieces, letters and meeting reports. The rejection rate was ca 80%. All articles since 1995 are
available on the Eurosurveillance
was founded in 1995 and jointly funded until March 2007 by the European Commission, the Institut de Veille Sanitaire (InVS) in Paris,
France and the Health Protection Agency (HPA) in London, United Kingdom. Eurosurveillance
is a registered trademark of the European Union (EU).
Since March 2007, Eurosurveillance
has been published by the European Centre for Disease Prevention and Control (ECDC) in Stockholm, Sweden.
ECDC funds this web site with its own resources; Eurosurveillance
does not have any other sources of funding. The publisher grants editorial
independence to the editorial team (http://www.eurosurveillance.eu/ViewArticle.aspx?ArticleId=19564
The views expressed in the journal are those of the authors and may not necessarily comply with ECDC policy.
As a non-profit publication, the journal has no financial conflicts of interest.
In January 2010, Eurosurveillance
was accredited by the Health on the Net (HON) Foundation
as adhering to the HON code of conduct (HONcode).
HON is a non-governmental, non-profit organisation with the purpose of supporting users to identify sound,
reliable and trustworthy health information on the Internet since 1995.
The editorial team is based in Stockholm, and supported by a board of 17 Associate editors and currently 39 country advisors.
The Associate editors consist of internationally renowned and active experts in the fields of public health and clinical medicine with expertise
in infectious diseases, laboratory research and diagnostics and mathematical modelling. Our editorial advisors serve as contacts in the
28 Member States as well as Norway and the EU candidate and potential candidate countries, and help us maintain close ties to our authors
and reviewers. The editorial board meets in person once a year but also provides ongoing advice through our extranet.
Board members serve for a period of three years which can be extended.
Dr Ines Steffens MD, MPH and DTM&PH
Kathrin Hagmaier, PhD
Karen Wilson, PhD
Williamina Wilson, DPhil
Alina Buzdugan, BA
Ingela Rumenius, BEc, MA
Sedki Alimam, Dragos Platon
ECDC ICT services
Contact the editorial team at:
Andrea Ammon, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden (resting associate editorship during tenure as acting Director of ECDC)
Tommi Asikainen, Brussels, Belgium
Magnus Boman, Royal Institute of Technology (KTH), Stockholm, Sweden
Mike Catchpole, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
Denis Coulombier, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
Natasha Crowcroft, Public Health Ontario and University of Toronto, Toronto, Canada
Christian Drosten, University of Bonn Medical Centre, Bonn, Germany
Karl Ekdahl, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
Johan Giesecke, Karolinska Institute, Stockholm, Sweden
David Heymann, Public Health England and London School of Hygiene & Tropical Medicine, London, United Kingdom
Heath Kelly, Victorian Infectious Disease Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, Melbourne and Australian National University, Canberra, Australia
Irena Klavs, National Institute of Public Health, Ljubljana, Slovenia
Karl Kristinsson, Landspitali University Hospital, Reykjavik, Iceland
Daniel Lévy-Bruhl, Santé publique France, Paris, France
Jacob Moran-Gilad, Ministry of Health, Jerusalem and Ben-Gurion University of the Negev, Beer-Sheva, Israel
Panayotis T. Tassios, National & Kapodistrian University of Athens, Athens, Greece
Hélène Therre, Santé publique France, Paris, France
Henriette de Valk, Santé publique France, Paris, France
Sylvie van der Werf, Pasteur Institute and University Paris Diderot, Paris, France
Albania: Alban Ylli, Tirana, affiliation to be confirmed
Austria: to be confirmed
Belgium: to be confirmed
Bosnia and Herzegovina: Sanjin Musa, Ministry of Health of the Federation of Bosnia and Herzegovina, Sarajevo
Bulgaria: Iva Christova, National Center of Infectious and Parasitic Diseases, Sofia
Croatia: Sanja Music Milanovic, Croatian National Institute of Public Health, Zagreb
Cyprus: Maria Koliou, Directorate of Medical and Public Health Services, Nicosia
Czech Republic: Jan Kynčl, National Institute of Public Health, Prague
Denmark: Peter Henrik Andersen, Statens Serum Institut, Copenhagen
Estonia: Kuulo Kutsar, Health Board, Tallinn
Finland: Outi Lyytikäinen, National Institute for Health and Welfare, Helsinki
France: Judith Benrekassa, Santé Publique France, Paris
Germany: Jamela Seedat, Robert Koch Institute, Berlin
Greece: Rengina Vorou, Hellenic Center for Diseases Control and Prevention, Athens
Hungary: Ágnes Hajdu, National Center for Epidemiology, Budapest
Iceland: Thorolfur Gudnason, Centre for Health Security and Communicable Disease Control, Reykjavík
Ireland: Lelia Thornton, Health Protection Surveillance Centre, Dublin
Italy: Paola De Castro, Istituto Superiore di Sanità, Rome
Kosovo under UN Security Council Resolution 1244: to be confirmed
Latvia: Dzintars Mozgis, Centre for Disease Prevention and Control, Riga
Lithuania: Milda Zygutiene, Centre for Communicable Diseases and AIDS, Vilnius
Luxembourg: Thérèse Staub, Centre Hospitalier de Luxembourg, Luxembourg
The former Yugoslav Republic of Macedonia: Aziz Pollozhani, Institute for Public Health of Republic of Macedonia, Skopje
Malta: Tanya Melillo Fenech, Superintendence of Public Health, Ministry of Health, The Elderly and Community Care, Msida
Montenegro: to be confirmed
Netherlands: Danielle Nijsten, RIVM National Institute for Public Health and the Environment, Bilthoven
Norway: Katrine Borgen, Norwegian Institute of Public Health, Oslo
Poland: Malgorzata Sadkowska-Todys, National Institute of Public Health – National Institute of Hygiene, Warsaw
Portugal: Paulo Jorge Nogueira, Directorate General of Health, Lisbon
Romania: Daniela Pitigoi, National Institute for Infectious Diseases "Prof.Dr.Matei Bals", Bucharest
Serbia: Mijomir Pelemis, Serbian Society for antimicrobial chemotherapy, Belgrade
Slovakia: Lukáš Murajda, affiliation to be confirmed
Slovenia: Maja Sočan, National Institute of Public Health, Ljubljana
Spain: Rosa Cano Portero, National Centre of Epidemiology, Instituto de Salud Carlos III, Madrid
Sweden: Anders Wallensten, Folkhälsomyndigheten, Stockholm
Turkey: Fehminaz Temel, Public Health Institution of Turkey, Ankara
United Kingdom: to be confirmed
World Health Organization Regional Office for Europe: Robb Butler, World Health Organization (Regional Office for Europe), Copenhagen, Denmark
To receive our electronic Table of contents click here to
The opinions expressed by authors contributing to Eurosurveillance
do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance
site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence
. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.